C

Curvebeam AI Ltd
ASX:CVB

Watchlist Manager
Curvebeam AI Ltd
ASX:CVB
Watchlist
Price: 0.125 AUD 8.7% Market Closed
Market Cap: 48.4m AUD
Have any thoughts about
Curvebeam AI Ltd?
Write Note

Operating Margin
Curvebeam AI Ltd

-334.2%
Current
-415%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-334.2%
=
Operating Profit
-21.8m
/
Revenue
6.5m

Operating Margin Across Competitors

Country US
Market Cap 48.4m AUD
Operating Margin
-334%
Country US
Market Cap 198.1B USD
Operating Margin
17%
Country US
Market Cap 186.8B USD
Operating Margin
26%
Country US
Market Cap 139B USD
Operating Margin
22%
Country US
Market Cap 131.1B USD
Operating Margin
18%
Country IE
Market Cap 103.9B USD
Operating Margin
19%
Country US
Market Cap 65.8B USD
Operating Margin
14%
Country DE
Market Cap 58.1B EUR
Operating Margin
12%
Country US
Market Cap 44.1B USD
Operating Margin
28%
Country CN
Market Cap 303.4B CNY
Operating Margin
36%
Country US
Market Cap 36.1B USD
Operating Margin
13%
No Stocks Found

Curvebeam AI Ltd
Glance View

Market Cap
48.4m AUD
Industry
Health Care

Curvebeam AI Ltd is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The firm is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.

CVB Intrinsic Value
0.288 AUD
Undervaluation 57%
Intrinsic Value
Price
C

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-334.2%
=
Operating Profit
-21.8m
/
Revenue
6.5m
What is the Operating Margin of Curvebeam AI Ltd?

Based on Curvebeam AI Ltd's most recent financial statements, the company has Operating Margin of -334.2%.